-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q1 2020 to Q1 2025.
- Barinthus Biotherapeutics plc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$14.9M, a 26.1% decline year-over-year.
- Barinthus Biotherapeutics plc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$28.9M, a 43.2% increase from 2023.
- Barinthus Biotherapeutics plc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$50.9M, a 253% decline from 2022.
- Barinthus Biotherapeutics plc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$14.4M, a 55.7% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)